2480 — Beijing Luzhu Biotechnology Co Balance Sheet
0.000.00%
- HK$4.60bn
- HK$3.95bn
Annual balance sheet for Beijing Luzhu Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 564 | 582 | 608 |
Total Inventory | |||
Prepaid Expenses | |||
Total Current Assets | 574 | 601 | 621 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 142 | 292 | 488 |
Net Intangible Assets | |||
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | 726 | 1,070 | 1,167 |
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 23.4 | 94.1 | 96.3 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 1,310 | 133 | 146 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | -585 | 937 | 1,021 |
Total Liabilities & Shareholders' Equity | 726 | 1,070 | 1,167 |
Total Common Shares Outstanding |